Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals several concerns: a significant net loss, declining revenue, increased operating costs, and cash flow challenges. Despite a promising pipeline and market growth, risks like digital asset volatility, customer concentration, and competitive pressures weigh heavily. The absence of a shareholder return plan and unclear management responses in the Q&A further exacerbate uncertainty. These factors likely lead to a negative stock price movement in the near term.
Net Loss for Q1 2026 $7.7 million, which includes $4.3 million in noncash losses on digital assets due to a decline in the price of the Aethir token. Excluding this, the operating loss was $3.4 million, reflecting the company's transition to its Compute Services segment.
Total Revenue for Q1 2026 $35,000, down from $110,000 in Q1 2025. The decrease is attributed to reduced sales in the legacy Drug Discovery Services business.
Operating Costs and Expenses for Q1 2026 $3.5 million, up from $2.4 million in Q1 2025. The increase was driven by a $1.1 million rise in general and administrative expenses, including severance expenses for the former CEO and other personnel-related costs.
Cash and Cash Equivalents as of March 31, 2026 $6.9 million, down from $10.8 million at December 31, 2025. The decrease reflects operational spending during the quarter.
Cash Used in Operating Activities for Q1 2026 $3.7 million, compared to $1 million in Q1 2025. The increase was due to higher working capital requirements and increased cash operating expenses.
Digital Asset Holdings as of March 31, 2026 $20.2 million, down from $24.4 million at December 31, 2025. The decrease was due to a mark-to-market adjustment tied to the decline in the market price of the Aethir token.
Digital Asset Receivable as of March 31, 2026 $15.4 million, with $9.4 million classified as current and $5.9 million as noncurrent. This represents locked Aethir tokens expected to vest through December 2028.
Total Assets as of March 31, 2026 $45.2 million, down from $52.9 million at December 31, 2025. The decrease was primarily driven by the $7.7 million net loss for the quarter.
Total Liabilities as of March 31, 2026 $5 million.
Total Stockholders' Equity as of March 31, 2026 $40.3 million, down from $47.7 million at December 31, 2025, primarily due to the net loss for the quarter.
Strategic Compute Reserve: Launched in September 2025, enabling Axe to own tokens to buy compute, which can be converted into cash quickly.
$260 Million Landmark Deal: Signed a 36-month agreement for 2,304 NVIDIA B300s with 4.8 megawatts of power in a U.S. Tier 3 data center, expected to generate $21 million per quarter starting Q3 2026.
Pipeline Growth: The company has a pipeline of $4.3 billion in potential contracts, with a focus on long-term commitments of 36 to 60 months.
Market Opportunity: Operating in a $1 trillion AI compute market growing at 30% CAGR through 2034.
Revenue Model: Customers pay monthly in advance, with 15%-30% prepayment upfront. Axe owns the hardware, which is redeployed after contract terms.
Financial Performance: Q1 2026 revenue was $35,000, with a net loss of $7.7 million, largely due to noncash losses on digital assets.
Business Model Evolution: Transitioned to focus on Compute Services, moving away from legacy Drug Discovery Services.
Leadership Changes: New CFO, Jeremy Yaukey-Witter, appointed to support the company's strategic direction.
Digital Asset Volatility: The company recorded a $4.3 million noncash mark-to-market loss on its digital asset holdings due to a decline in the price of the Aethir token during Q1 2026. This volatility in digital asset value poses a financial risk.
Revenue Decline in Legacy Business: Revenue from the legacy Drug Discovery Services business decreased significantly, reflecting reduced sales and ongoing strategic evaluation, which could impact overall revenue stability.
Operational Losses: The company reported an underlying operating loss of $3.4 million, driven by increased operating costs and transitional expenses, which could strain financial resources.
Cash Flow Challenges: Cash and cash equivalents decreased by $3.9 million during the quarter, reflecting operational spending and increased cash used in working capital, which could impact liquidity.
Supply Chain and Build-Out Risks: The company faces risks related to orchestrating lead times for hardware components and securing data center space and power for large-scale projects, which could delay deployments and revenue recognition.
Customer Concentration Risk: The $260 million landmark deal represents a significant portion of expected revenue, creating dependency on a single large customer and potential vulnerability if the deal faces issues.
Market Competition: The company operates in a highly competitive market for AI compute services, facing pressure from traditional hyperscalers and other neocloud providers, which could impact market share and pricing.
Economic and Regulatory Uncertainty: The company’s operations and financial performance could be affected by broader economic conditions and regulatory changes in the technology and digital asset sectors.
Revenue Projections: The company expects to generate $21 million per quarter in revenue from a 36-month agreement for 2,304 NVIDIA B300s at 4.8 megawatts of dedicated power in a U.S. Tier 3 data center, starting in Q3 2026.
Pipeline and Future Deals: The company has a pipeline of over $4.3 billion in qualified deals, representing over 36,000 GPUs. Management expects to close around $1 billion in transactions in 2026, with potential incremental contracted revenue in the hundreds of millions of dollars.
Market Trends: The AI compute market is estimated to have crossed $1 trillion in 2026, growing at a 30% CAGR through 2034. Total data center CapEx is projected to exceed $6.7 trillion through 2030.
Business Model and Asset Growth: The company plans to build and own AI infrastructure globally, with assets amortized over 3 to 5 years. This model is expected to generate positive cash flow and build long-term asset value.
Customer Commitments: Most customer deals are expected to have 36 to 60-month commitments, reflecting long-term infrastructure decisions by enterprises.
The selected topic was not discussed during the call.
The earnings call reveals several concerns: a significant net loss, declining revenue, increased operating costs, and cash flow challenges. Despite a promising pipeline and market growth, risks like digital asset volatility, customer concentration, and competitive pressures weigh heavily. The absence of a shareholder return plan and unclear management responses in the Q&A further exacerbate uncertainty. These factors likely lead to a negative stock price movement in the near term.
The earnings call highlights strategic initiatives like AI infrastructure expansion and leadership changes, which are positive long-term. However, the lack of financial details and potential risks from leadership transition and competitive challenges in AI temper enthusiasm. The neutral sentiment is due to the absence of immediate financial catalysts or shareholder return discussions.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.